| Line Item | 2024-04-30 | Y/Y |
|---|---|---|
| Revenue | $716.7M | +32.6% |
| Cost of Revenue | $432.8M | +17.9% |
| Gross Profit | $283.9M | +63.6% |
| R&D Expense | $97.7M | +52.0% |
| SG&A Expense | $114.4M | -13.3% |
| Operating Income | $71.8M | +140.2% |
| Pre-tax Income | $61.6M | +132.3% |
| Income Tax | $1.9M | +112.9% |
| Net Income | $59.7M |
| Line Item | 2024-04-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $73.3M | -44.8% |
| Accounts Receivable | $70.3M | -19.8% |
| Inventory | $150.2M | +8.2% |
| Current Assets | $515.6M | +8.1% |
| Total Assets | $1.02B | +23.2% |
| Current Liabilities | $144.9M | +19.4% |
| Long-term Debt | $28.0M | -79.3% |
| Line Item | 2024-04-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $15.3M | +34.1% |
| Capital Expenditures | $23.0M | +54.6% |
| Investing Cash Flow | -$51.7M | -638.5% |
| Financing Cash Flow | -$22.9M | -145.0% |
| Free Cash Flow | -$7.7M | -121.8% |
| +133.9% |
| EPS (Basic) | $2.19 | +131.1% |
| EPS (Diluted) | $2.18 | +131.0% |
| Stockholders' Equity |
| $822.7M |
| +49.3% |